It’s time to cast your vote! As a member of the Investor Collective, you have the ability to designate how the group’s funds will support the Cancer Center’s mission over the next year. Voting begins Monday, May 12 and ends Friday, May 16 at 12 p.m.
We are proud to present three mission-critical programs that are vying for the Collective’s support. You can choose a specific program or vote for all three.
Medical Physics Program
The Medical Physics team is focused on integrating innovative technologies, such as artificial intelligence and precision radiation therapy, to improve patient outcomes and ensure every treatment plan is personalized to maximize effectiveness and minimize side effects.
Education is also central to our efforts. Mary Bird Perkins’ collaboration with Louisiana State University (LSU) has established a nationally recognized training program for future medical physicists, reinforcing our commitment to shaping the next generation of leaders in cancer care. These educational programs have created an academic environment that is truly unique in the community setting and carries tremendous benefits to our patients.
Professional Education
As the healthcare industry is constantly changing and with new developments, technologies, rules and regulations, it is critical for healthcare professionals to continuously evolve their wealth of knowledge throughout one’s career. Supporting professional education ensures all physicians, oncology health clinicians and supportive team members have the opportunity to continue seeking best practices in caring for patients and enhance care throughout the organization.
Multiple Myeloma Program
Multiple myeloma is a blood and bone marrow cancer that occurs when healthy plasma cells—normally responsible for producing antibodies— turn cancerous. At Mary Bird Perkins, Dr. Andy Dalovisio, a hematologic oncologist, leads the Cancer Center’s myeloma, lymphoma, and cellular therapy program. As a dedicated multiple myeloma specialist, he is delivering the most advanced therapies available, including immunotherapy and cutting-edge cellular treatments.
Louisiana ranks among the top ten states in the nation for myeloma incidence—making local access to this level of specialized care more critical than ever. Philanthropic support will allow us to build a dedicated program, accelerate its launch, and expand access for patients in our region who would otherwise have to travel for treatment to receive this kind of care.
Since 2017, the Investor Collective has contributed over $1.5 million to improve survivorship and lessen the burden of cancer in our community. You will be a part of an influential group dedicated to ensuring access to state-of-the-art treatment and essential support services for cancer patients and their families in their time of need.
With a $1,000 tax-deductible annual donation, you have the opportunity to:
RECEIVE personalized support and navigation should you—or your family—ever need advice about how to prevent, detect, or treat cancer
VOTE on how members’ collective donations will support the Cancer Center’s mission
ATTEND Pro Series events offering education on health-related topics led by local physicians
NETWORK with fellow members at annual gatherings and see the impact of your contributions
Thank you for your commitment to the Investor Collective.
We are here for you, should you ever need us.
Susan Maxwell
P: (225) 215-1166 | C: (225) 329-7600
smaxwell@marybird.com
Mellie Bailey
P: (225) 215-1158 | C: (225) 445-5571
mbailey@marybird.com
Patricia Lemoine
P: (225) 215-1340 | C: (706) 247-5698
plemoine@marybird.com